Formatech has developed and patented its neuNanoParticle® technology as a platform to solubilize and deliver hydrophobic pharmaceutical compounds. This technology effectively solubilized pharmaceutical compounds in micellar formulations containing fatty acids and/or fatty alcohols. neuNanoParticle formulations are pharmaceutically acceptable and have demonstrated improved safety and efficacy in a number of preclinical studies.

neuNanoParticle Technology Advantages:

• Eliminate the need for solvents and/or undesirable excipients, such as Cremophore®
  
• Compatible with lyophilization
  
• Compatible with all common routes of administration

Formatech is currently developing neuNanoParticle formulations for commercial products that are or will soon come off patent. We are evaluating options to commercialize this technology that will include  partnership, co-development and/or licensing strategies.

neuNanoParticle Development Programs

• neuDocetaxel Program
  
• neuPaclitaxel Program
  
• neuPropofol Program